EHS
EHS

FDA Fast Track Designation Granted to Praliciguat for HFpEF

The Company is currently enrolling patients in a randomized, double-blind, placebo-controlled Phase 2 trial; they expect to enroll 175 in total.

Source link

EHS
Back to top button